Tirdzniecība Nanostrg Te - NSTG CFD
Pievienot izlasei- Kopsavilkums
- Vēsturiskie Dati
- Notikumi
- Peļņas Atskaite
- Bilance
- Naudas Plūsma
- Īpašums
Tirdzniecības Nosacījumi
| Starpība | - | ||||||||
|
Garās pozīcijas nodeva naktij
Long position overnight fee
Doties uz platformu | -0.030779% | ||||||||
|
Īsās pozīcijas nodeva naktij
Short position overnight fee
Doties uz platformu | -0.013666% | ||||||||
| Nakts laika nodeva | 22:00 (UTC) | ||||||||
| Min. tirgotais daudzums | 1 | ||||||||
| Valūta | USD | ||||||||
| Drošības rezerve | 20% | ||||||||
| Fondu birža | United States of America | ||||||||
| Tirdzniecības komisija | 0% |
*Information provided by Capital.com
Galvenie Statistikas Dati
| Iepriekš. aizvērt* | N/A |
| Atvērt* | N/A |
| Izmaiņas par 1 gadu* | N/A |
| Dienas Diapazons* | N/A |
| 52 ned Diapazons | 4.37-41.00 |
| Vidējais apjoms (10 dienas) | 548.51K |
| Vidējais apjoms (3 mēneši) | 16.41M |
| Tirgus Kapitalizācija | 568.16M |
| Cenas/Peļņas Attiecība | -100.00K |
| Izvietotās Akcijas | 46.65M |
| Ieņēmumi | 135.30M |
| EPS | -3.13 |
| Dividende (Ienesīgums %) | N/A |
| Beta | 1.59 |
| Nākamās Peļņas Datums | Feb 27, 2023 |
"Visus datus nodrošina Refinitiv, izņemot datus, kas atzīmēti ar zvaigznīti, kas ir *dati, kurus nodrošina Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Aizvēršana | Change | Change (%) | Atvēršana | High | Low |
|---|
Nanostrg Te Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Ikgadējs
- Ceturkšņa
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Kopējie ienākumi | 86.489 | 114.905 | 106.732 | 125.568 | 117.316 | 145.085 |
| Ienākumi | 86.489 | 114.905 | 106.732 | 125.568 | 117.316 | 145.085 |
| Cost of Revenue, Total | 30.245 | 31.88 | 36.331 | 44.039 | 52.409 | 68.304 |
| Bruto Peļņa | 56.244 | 83.025 | 70.401 | 81.529 | 64.907 | 76.781 |
| Kopējie Darbības Izdevumi | 127.665 | 153.102 | 176.125 | 159.398 | 212.506 | 253.311 |
| Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 62.7 | 74.334 | 78.195 | 96.195 | 90.097 | 115.503 |
| Pētniecība un Attīstība | 34.72 | 46.888 | 61.599 | 68.035 | 62.857 | 69.504 |
| Darbības Izdevumi | -41.176 | -38.197 | -69.393 | -33.83 | -95.19 | -108.226 |
| Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -5.282 | -5.344 | -6.1 | -5.668 | -13.664 | -6.841 |
| Citi, Neto | -0.515 | 0.183 | -1.658 | -0.929 | -0.971 | -0.02 |
| Neto Ienākumi Pirms Nodokļu Nomaksas | -46.973 | -43.358 | -77.151 | -40.427 | -109.825 | -115.087 |
| Neto Ienākumi Pēc Nodokļu Nomaksas | -47.089 | -5.872 | -77.4 | -40.696 | -110.078 | -115.254 |
| Neto Ienākumi Pirms Ārkārtas Posteņiem | -47.089 | -5.872 | -77.4 | -40.696 | -110.078 | -115.254 |
| Neto Ienākumi | -47.089 | -43.562 | -77.4 | -40.696 | -110.078 | -115.254 |
| Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -47.089 | -5.872 | -77.4 | -40.696 | -110.078 | -115.254 |
| Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -47.089 | -43.562 | -77.4 | -40.696 | -110.078 | -115.254 |
| Atšķaidītie Neto Ienākumi | -47.089 | -43.562 | -77.4 | -40.696 | -110.078 | -115.254 |
| Atšķaidītie Ienākumi par Akcijām | 20.116 | 23.731 | 27.883 | 34.588 | 39.083 | 45.299 |
| Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -2.34087 | -0.24744 | -2.77588 | -1.17659 | -2.81652 | -2.54429 |
| Atšķaidītā Normalizētā Peļņa par Akciju | -2.34087 | -0.24744 | -2.77588 | -2.09501 | -2.69772 | -2.54429 |
| Ārkārtas Posteņi Kopā | -37.69 | 0 | ||||
| Neparedzēti Izdevumi (Ienākumi) | -48.871 | 7.143 | 0 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Kopējie ienākumi | 31.617 | 33.863 | 37.15 | 42.455 | 31.08 |
| Ienākumi | 31.617 | 33.863 | 37.15 | 42.455 | 31.08 |
| Cost of Revenue, Total | 15.623 | 15.481 | 17.154 | 20.046 | 14.778 |
| Bruto Peļņa | 15.994 | 18.382 | 19.996 | 22.409 | 16.302 |
| Kopējie Darbības Izdevumi | 57.485 | 59.498 | 66.524 | 69.804 | 68.55 |
| Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 26.799 | 26.855 | 30.253 | 31.596 | 36.355 |
| Pētniecība un Attīstība | 15.063 | 17.162 | 19.117 | 18.162 | 17.417 |
| Neparedzēti Izdevumi (Ienākumi) | 0 | 0 | 0 | 0 | |
| Darbības Izdevumi | -25.868 | -25.635 | -29.374 | -27.349 | -37.47 |
| Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -1.752 | -1.637 | -1.723 | -1.729 | -1.732 |
| Citi, Neto | -0.032 | 0.334 | -0.223 | -0.099 | -0.217 |
| Neto Ienākumi Pirms Nodokļu Nomaksas | -27.652 | -26.938 | -31.32 | -29.177 | -39.419 |
| Neto Ienākumi Pēc Nodokļu Nomaksas | -27.712 | -27.02 | -31.261 | -29.261 | -39.5 |
| Neto Ienākumi Pirms Ārkārtas Posteņiem | -27.712 | -27.02 | -31.261 | -29.261 | -39.5 |
| Neto Ienākumi | -27.712 | -27.02 | -31.261 | -29.261 | -39.5 |
| Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -27.712 | -27.02 | -31.261 | -29.261 | -39.5 |
| Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -27.712 | -27.02 | -31.261 | -29.261 | -39.5 |
| Atšķaidītie Neto Ienākumi | -27.712 | -27.02 | -31.261 | -29.261 | -39.5 |
| Atšķaidītie Ienākumi par Akcijām | 44.669 | 45.274 | 45.558 | 45.686 | 45.998 |
| Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -0.62039 | -0.59681 | -0.68618 | -0.64048 | -0.85873 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Atšķaidītā Normalizētā Peļņa par Akciju | -0.62039 | -0.59681 | -0.68618 | -0.64048 | -0.85873 |
- Ikgadējs
- Ceturkšņa
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Apgrozāmo Līdzekļu Kopsumma | 113.785 | 121.921 | 131.707 | 212.607 | 498.98 | 427.62 |
| Nauda un Īstermiņa Ieguldījumi | 74.036 | 77.555 | 93.997 | 156.855 | 440.731 | 348.889 |
| Nauda un Ekvivalenti | 20.583 | 26.136 | 24.356 | 29.033 | 411.848 | 107.068 |
| Īstermiņa Ieguldījumi | 53.453 | 51.419 | 69.641 | 127.822 | 28.883 | 241.821 |
| Debitoru Parādu Kopsumma, Neto | 22.379 | 19.564 | 17.279 | 27.153 | 31.1 | 40.13 |
| Accounts Receivable - Trade, Net | 22.193 | 19.564 | 17.279 | 27.153 | 31.1 | 40.13 |
| Total Inventory | 13.812 | 20.057 | 13.173 | 19.781 | 22.959 | 31.486 |
| Other Current Assets, Total | 3.558 | |||||
| Total Assets | 126.373 | 136.762 | 147.558 | 259.754 | 544.195 | 479.481 |
| Property/Plant/Equipment, Total - Net | 12.158 | 14.057 | 15.171 | 44.832 | 42.32 | 46.269 |
| Property/Plant/Equipment, Total - Gross | 26.974 | 31.305 | 32.101 | 63.083 | 65.361 | 74.729 |
| Accumulated Depreciation, Total | -14.816 | -17.248 | -16.93 | -18.251 | -23.041 | -28.46 |
| Other Long Term Assets, Total | 0.43 | 0.784 | 0.68 | 2.315 | 2.895 | 5.592 |
| Total Current Liabilities | 36.383 | 35.919 | 43.115 | 44.986 | 37.099 | 52.155 |
| Accounts Payable | 4.935 | 4.092 | 8.636 | 10.282 | 5.313 | 14.283 |
| Accrued Expenses | 12.344 | 13.141 | 15.765 | 24.318 | 24.545 | 29.12 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0.058 | 0 | ||||
| Other Current Liabilities, Total | 19.046 | 18.686 | 18.714 | 10.386 | 7.241 | 8.752 |
| Total Liabilities | 114.068 | 96.653 | 110.689 | 155.603 | 237.247 | 302.519 |
| Total Long Term Debt | 47.366 | 48.931 | 58.396 | 79.951 | 172.703 | 225.144 |
| Long Term Debt | 47.366 | 48.931 | 58.396 | 79.951 | 172.703 | 225.144 |
| Other Liabilities, Total | 30.319 | 11.803 | 9.178 | 30.666 | 27.445 | 25.22 |
| Total Equity | 12.305 | 40.109 | 36.869 | 104.151 | 306.948 | 176.962 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 0.002 | 0.002 | 0.003 | 0.004 | 0.004 | 0.005 |
| Additional Paid-In Capital | 281.9 | 353.308 | 428.162 | 535.954 | 848.891 | 827.028 |
| Retained Earnings (Accumulated Deficit) | -269.54 | -313.102 | -391.256 | -431.952 | -542.03 | -649.753 |
| Other Equity, Total | -0.057 | -0.099 | -0.04 | 0.145 | 0.083 | -0.318 |
| Total Liabilities & Shareholders’ Equity | 126.373 | 136.762 | 147.558 | 259.754 | 544.195 | 479.481 |
| Total Common Shares Outstanding | 21.528 | 25.421 | 30.913 | 36.298 | 44.441 | 45.729 |
| Prepaid Expenses | 4.745 | 7.258 | 8.818 | 4.19 | 7.115 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Apgrozāmo Līdzekļu Kopsumma | 474.445 | 466.137 | 445.967 | 427.62 | 387.13 |
| Nauda un Īstermiņa Ieguldījumi | 409.918 | 398.018 | 369.854 | 348.889 | 312.075 |
| Nauda un Ekvivalenti | 396.502 | 160.38 | 107.167 | 107.068 | 98.457 |
| Īstermiņa Ieguldījumi | 13.416 | 237.638 | 262.687 | 241.821 | 213.618 |
| Debitoru Parādu Kopsumma, Neto | 33.183 | 32.046 | 35.47 | 40.13 | 30.381 |
| Accounts Receivable - Trade, Net | 33.183 | 32.046 | 35.47 | 40.13 | 30.381 |
| Total Inventory | 24.434 | 28.697 | 31.095 | 31.486 | 34.59 |
| Prepaid Expenses | 6.91 | 7.376 | 9.548 | 7.115 | 10.084 |
| Total Assets | 520.558 | 513.058 | 493.384 | 479.481 | 444.72 |
| Property/Plant/Equipment, Total - Net | 42.433 | 41.461 | 40.273 | 46.269 | 51.266 |
| Other Long Term Assets, Total | 3.68 | 5.46 | 7.144 | 5.592 | 6.324 |
| Total Current Liabilities | 33.639 | 43.123 | 44.48 | 52.155 | 49.586 |
| Accounts Payable | 5.811 | 10.963 | 11.932 | 14.283 | 18.426 |
| Accrued Expenses | 19.782 | 24.295 | 24.796 | 29.12 | 21.845 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 8.046 | 7.865 | 7.752 | 8.752 | 9.315 |
| Total Liabilities | 284.166 | 293.331 | 294.265 | 302.519 | 299.415 |
| Total Long Term Debt | 224.07 | 224.424 | 224.785 | 225.144 | 225.511 |
| Long Term Debt | 224.07 | 224.424 | 224.785 | 225.144 | 225.511 |
| Other Liabilities, Total | 26.457 | 25.784 | 25 | 25.22 | 24.318 |
| Total Equity | 236.392 | 219.727 | 199.119 | 176.962 | 145.305 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 |
| Additional Paid-In Capital | 798.589 | 809.015 | 819.63 | 827.028 | 835.845 |
| Retained Earnings (Accumulated Deficit) | -562.211 | -589.231 | -620.492 | -649.753 | -689.253 |
| Other Equity, Total | 0.009 | -0.062 | -0.024 | -0.318 | -1.292 |
| Total Liabilities & Shareholders’ Equity | 520.558 | 513.058 | 493.384 | 479.481 | 444.72 |
| Total Common Shares Outstanding | 45.205 | 45.502 | 45.639 | 45.729 | 46.402 |
- Ikgadējs
- Ceturkšņa
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Neto ienākumi/Sākuma Līnija | -47.089 | -43.562 | -77.4 | -40.696 | -110.078 | -115.254 |
| Nauda no Darbības | -6.079 | -51.657 | -54.065 | -89.421 | -81.662 | -90.549 |
| Nauda no Darbības | 2.977 | 3.354 | 4.07 | 4.919 | 5.738 | 5.871 |
| Bezskaidras Naudas Preces | 10.531 | 14.452 | 10.372 | -25.438 | 37.227 | 35.332 |
| Cash Taxes Paid | 0.217 | 0.154 | 0.231 | 0.265 | 0.357 | 0.189 |
| Samaksātie Procenti Naudā | 4.071 | 4.416 | 6.213 | 5.683 | 4.571 | 6.038 |
| Izmaiņas Apgrozāmajā Kapitālā | 27.502 | -25.901 | 8.893 | -28.206 | -14.549 | -16.498 |
| Nauda no Ieguldījumu Darbībām | -30.261 | -2.49 | -22.925 | -15.159 | 91.241 | -220.222 |
| Kapitālie Izdevumi | -3.991 | -4.284 | -4.485 | -7.885 | -7.457 | -8.647 |
| Citi Ieguldījumu Naudas Plūsmas Posteņi, Kopā | -26.27 | 1.794 | -18.44 | -7.274 | 98.698 | -211.575 |
| Nauda no Darbībām ar Finansēšanu | 35.093 | 59.668 | 75.081 | 109.266 | 373.048 | 6.058 |
| Naudas Plūsma Finansēšanas Posteņos | 0 | -0.313 | -1.716 | -1.574 | -14.26 | -2.585 |
| Akciju Izsniegšana (Atkāpšanās), Neto | 30.319 | 60.039 | 61.797 | 90.84 | 237.443 | 8.879 |
| Parādu Izsniegšana (Atkāpšanās), Neto | 4.774 | -0.058 | 15 | 20 | 149.865 | -0.236 |
| Ārvalstu Valūtas Ietekme | -0.026 | 0.032 | -0.014 | -0.009 | 0.188 | -0.067 |
| Neto Izmaiņas Naudā | -1.273 | 5.553 | -1.923 | 4.677 | 382.815 | -304.78 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -27.712 | -54.732 | -85.993 | -115.254 | -39.5 |
| Cash From Operating Activities | -28.856 | -44.167 | -73.03 | -90.549 | -30.253 |
| Cash From Operating Activities | 1.441 | 2.88 | 4.347 | 5.871 | 1.543 |
| Non-Cash Items | 9.591 | 16.753 | 27.133 | 35.332 | 10.2 |
| Changes in Working Capital | -12.176 | -9.068 | -18.517 | -16.498 | -2.496 |
| Cash From Investing Activities | 12.69 | -210.283 | -236.83 | -220.222 | 20.705 |
| Capital Expenditures | -2.672 | -3.784 | -5.355 | -8.647 | -5.919 |
| Other Investing Cash Flow Items, Total | 15.362 | -206.499 | -231.475 | -211.575 | 26.624 |
| Cash From Financing Activities | 0.856 | 2.991 | 5.219 | 6.058 | 0.96 |
| Financing Cash Flow Items | -2.585 | -2.585 | -2.585 | -2.585 | -1.504 |
| Issuance (Retirement) of Stock, Net | 3.441 | 5.695 | 7.974 | 8.879 | 2.537 |
| Issuance (Retirement) of Debt, Net | 0 | -0.119 | -0.17 | -0.236 | -0.073 |
| Foreign Exchange Effects | -0.036 | -0.009 | -0.04 | -0.067 | -0.023 |
| Net Change in Cash | -15.346 | -251.468 | -304.681 | -304.78 | -8.611 |
| Investora vārds | Investora veids | Nenokārtots procents | Akcijas turējumā | Izmaiņas akcijās | Turēšanas termiņš | Apgrozījuma reitings |
|---|---|---|---|---|---|---|
| Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 13.8356 | 6453874 | 724088 | 2022-12-30 | LOW |
| RA Capital Management, LP | Hedge Fund | 9.8667 | 4602478 | 1018000 | 2022-09-30 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 9.4297 | 4398638 | -1586373 | 2022-09-30 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 7.3808 | 3442915 | -104746 | 2022-09-30 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 7.2608 | 3386909 | -63219 | 2022-09-30 | LOW |
| Polar Capital LLP | Investment Advisor/Hedge Fund | 5.5231 | 2576357 | 550188 | 2022-09-30 | LOW |
| Pura Vida Investments, LLC | Hedge Fund | 5.0797 | 2369500 | 1605800 | 2022-10-31 | MED |
| Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 3.335 | 1555648 | -41556 | 2022-09-30 | LOW |
| Two Sigma Investments, LP | Hedge Fund | 2.2071 | 1029534 | -169199 | 2022-09-30 | HIGH |
| Managed Account Advisors LLC | Investment Advisor | 2.1753 | 1014709 | 646498 | 2022-09-30 | LOW |
| Camber Capital Management LP | Hedge Fund | 2.1438 | 1000000 | 150000 | 2022-09-30 | MED |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.0228 | 943576 | 17545 | 2022-09-30 | LOW |
| Balyasny Asset Management LP | Hedge Fund | 2.0059 | 935681 | 935681 | 2022-09-30 | |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.7205 | 802578 | -7509 | 2022-09-30 | LOW |
| D. E. Shaw & Co., L.P. | Hedge Fund | 1.7047 | 795201 | 258596 | 2022-09-30 | HIGH |
| Assenagon Asset Management S.A. | Investment Advisor | 1.5509 | 723444 | -14061 | 2022-12-31 | HIGH |
| Avidity Partners Management LP | Hedge Fund | 1.4968 | 698200 | 698200 | 2022-09-30 | MED |
| Fisher Investments | Investment Advisor/Hedge Fund | 1.4229 | 663722 | 22279 | 2022-12-31 | LOW |
| Barclays Capital Inc. | Research Firm | 1.3732 | 640553 | 640523 | 2022-09-30 | HIGH |
| BMO Capital Markets (US) | Research Firm | 1.3362 | 623294 | -2889 | 2022-12-31 | LOW |
Kāpēc izvēlēties Capital.com? Mūsu skaitļi runā paši par sevi.
Capital.com Group +500000+
Tirgotāji
93000+
Ikmēneša aktīvie klienti
$57000000+
Ikmēneša ieguldījumu apjoms
$31000000+
Izmēģināt tagad Izņemts katru mēnesi
Treidinga kalkulators
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Tirdzniecības komisija
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Finanšu svira
20:1
- 20
- 100
- 500
- 1000
- 10000
Investīcija
Darījuma apjoms (Kredītplecs x Investīcija):
Atvēršana
Aizvēršana
Īss Garšs
Nanostrg Te Company profile
Par Nanostrg Te
NanoString Technologies, Inc. izstrādā, ražo un pārdod bioloģiskā materiāla produktus. Tās pamattehnoloģija ietver ķīmiskās vielas, kas ļauj marķēt un skaitīt atsevišķas molekulas. Vienas molekulas ķīmiskās vielas ļauj tieši noteikt, identificēt un kvantificēt atsevišķas mērķa molekulas bioloģiskajos paraugos, pievienojot molekulāros ziņotājus katrai interesējošajai mērķa molekulai. Uzņēmums izmanto savu pamattehnoloģiju, lai izstrādātu rīkus zinātniskiem un klīniskiem pētījumiem. Uzņēmums piedāvā divas produktu platformas, tostarp nCounter Analysis System un GeoMx Digital Spatial Profiler (GeoMx DSP) sistēmas. Sistēmu nCounter Analysis System izmanto, lai analizētu gēnu aktivitāti vienā eksperimentā, un to izmanto arī klīnicisti, lai analizētu gēnu aktivitāti diagnostikas vajadzībām. GeoMx DSP izmanto, lai atvieglotu bioloģiskā parauga izvēlētu reģionu analīzi, lai redzētu, kā mainās gēnu aktivitāte šajos reģionos vai noteiktos šūnu tipos.
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
530 Fairview Avenue North
SEATTLE
WASHINGTON 98109
US
Peļņas Atskaite
- Annual
- Quarterly
Cilvēki arī skatās
Vai joprojām meklējat mākleri, kuram varat uzticēties?
Pievienojieties 500 000+ tirgotājiem visā pasaulē, kuri izvēlējās tirgoties ar Capital.com